Stocks / BVS vs HROW

Bioventus Inc. (BVS) vs Harrow, Inc. (HROW)

Bioventus Inc. and Harrow, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

HROW is the larger company ($1.4B vs $0.6B). On the fundamentals, HROW grows revenue faster (41.0% vs 12.1%); BVS earns a higher net margin (4.0% vs -1.9%); BVS has the stronger return on equity (12.3% vs -9.8%). Over the last five years, HROW returned 298.3% vs -50.5%. On the filings, BVS carries fewer potential red flags (1 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — BVS vs HROW, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Bioventus Inc. (BVS)Harrow, Inc. (HROW)
Market cap$0.6B$1.4B
Revenue (latest FY)$568.09M$272.30M
Net income (latest FY)$22.73M$-5.14M
Revenue growth (5y CAGR)12.1%41.0%
Net margin4.0%-1.9%
Return on equity12.3%-9.8%
P/E ratio21.2
Dividend yield
Profitable years (of last 10)42
Positive free cash flowYesYes

Performance — BVS vs HROW

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Bioventus Inc. (BVS)Harrow, Inc. (HROW)
1-year return31.6%21.2%
3-year return201.4%94.3%
5-year return-50.5%298.3%
10-year return884.0%
52-week range$5.81–$11.25$28.54–$54.85

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full BVS vs HROW breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open BVS's full financials →   Open HROW's full financials →

More comparisons

Frequently asked questions

Which is bigger, BVS or HROW?

Harrow, Inc. is larger by market capitalization — $1.4B versus $0.6B.

Which grows faster, BVS or HROW?

Over the last five fiscal years, Harrow, Inc. grew revenue faster — 41.0%/yr versus 12.1%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

BVS fundamentals → · HROW fundamentals → · All 1,500+ companies → · Free screener →